News Evotec SE CBOE

Stocks

0IRF

DE0005664809

Biotechnology & Medical Research

Market Closed - CBOE 01:30:00 20/08/26 am AEST			After hours 05:15:28 am
3.724 ^EUR	0.00%		3.399	-8.73%

13/08	Energiekontor hits March low, doubts over a strong second half	DP
13/08	Evotec's final first-half results once again spook investors	DP

All News

Mentions Relevance

13/08	Evotec's final first-half results once again spook investors	DP
13/08	Evotec SE Reports Earnings Results for the Half Year Ended June 30, 2026	CI
13/08	Evotec SE : Gets a Buy rating from RBC	ZD
13/08	Evotec : Half-year report 2026, PDF (H1 Report 2026 English)	PU
13/08	Evotec : Half-year report 2026, PDF (Interim Statement H1 2026 English)	PU
13/08	Evotec Se Announces Camilla Macapili Languille Step Down as Supervisory Board, Effective August 7, 2026	CI
13/08	Evotec Se Reaffirms Earnings Guidance for the Full-Year 2026	CI
06/08	Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments	MT
06/08	Evotec, Odyssey Therapeutics Team Up on Autoimmune, Inflammatory Disease Treatment Research	MT
06/08	Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases	EQ
06/08	Evotec : and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases	PU
04/08	Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168	CI
03/08	Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168	MT
16/07	Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40	MT
16/07	EVOTEC : Deutsche Bank reaffirms its Neutral rating	ZD
16/07	EVOTEC : Reduced to Neutral by Berenberg	ZD
16/07	Berenberg downgrades Evotec to 'Hold', target cut to €3.60	DP
16/07	Evotec Shares Fall After TD Cowen Downgrade	MT
15/07	TD Cowen Downgrades Evotec to Hold From Buy, Adjusts Price Target to $2 From $4	MT
14/07	Evotec SE, Q2 2026 Earnings Call, Jul 14, 2026
14/07	Evotec plunges after profit warning to lowest share price in ten years	DP
14/07	EVOTEC : Deutsche Bank reaffirms its Neutral rating	ZD
14/07	Evotec abandons profit hopes, shares slide	DP
14/07	EVOTEC : RBC gives a Buy rating	ZD
14/07	Evotec at risk of lowest share price in ten years after profit warning	DP